lilly compound tirzepatide launches lower-price weight-loss drug Zepbound without injector pen Lilly demands doctors stop selling

And while the study compared GLP-1 RAs broadly (not tirzepatide specifically), tirzepatide is a GLP-1 RA with additional GIP activity that may confer extra cardiovascular benefit

Lee JH, Sahu A, Jang C, Tae G

Professor Linong Ji, the principal investigator of the study, Peking University People's Hospital, stated, "Accumulated evidence showed that Chinese people generally have higher percentages of body fat and higher rates of cardiovascular risk factors and all-cause mortality than western population at given BMI levels, therefore overweight and obesity in adults in China are defined with lower BMI cutoffs (overweight cutoff BMI 24 kg/m 2 , obesity cutoff BMI 28 kg/m 2 )

Nu bn th qua cc loi lm trng da ni sinh khc m khng thy s thay i r rt, c th bn cha tm ra cht chng oxy ho mnh cho c th bn